Home > Reports, Tools, & Publications > Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom

Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom

Vanessa C Brunetti, Audray St-Jean, Sophie Dell'Aniello, Anat Fisher, Oriana H Y Yu, Shawn C Bugden, Jean-Marc Daigle, Nianping Hu, Silvia Alessi-Severini, Baiju R Shah, Paul E Ronksley, Lisa M Lix, Pierre Ernst, Kristian B Filion
BMC endocrine disorders
September 29, 2022

Citation

Brunetti, V. C., St-Jean, A., Dell’Aniello, S., Fisher, A., Yu, O. H. Y., Bugden, S. C., Daigle, J. M., Hu, N., Alessi-Severini, S., Shah, B. R., Ronksley, P. E., Lix, L. M., Ernst, P., Filion, K. B., & Canadian Network for Observational Drug Effect Studies (CNODES) Investigators (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. BMC endocrine disorders22(1), 241.

https://doi.org/10.1186/s12902-022-01140-